Dystrophy Stocks List

Recent Signals

Date Stock Signal Type
2021-05-06 BLUE Hammer Candlestick Bullish
2021-05-06 BLUE Bollinger Band Squeeze Range Contraction
2021-05-06 BLUE Pocket Pivot Bullish Swing Setup
2021-05-06 BLUE 20 DMA Support Bullish
2021-05-06 BMY Fell Below 20 DMA Bearish
2021-05-06 DYN Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-05-06 DYN 20 DMA Support Bullish
2021-05-06 ELMD Bollinger Band Squeeze Range Contraction
2021-05-06 ELMD Stochastic Reached Oversold Weakness
2021-05-06 FIXX New 52 Week Closing Low Bearish
2021-05-06 FIXX New 52 Week Low Weakness
2021-05-06 FULC Bullish Engulfing Bullish
2021-05-06 FULC Lower Bollinger Band Walk Weakness
2021-05-06 FULC Pocket Pivot Bullish Swing Setup
2021-05-06 IONS MACD Bearish Signal Line Cross Bearish
2021-05-06 IONS New 52 Week Closing Low Bearish
2021-05-06 IONS New 52 Week Low Weakness
2021-05-06 IONS New Downtrend Bearish
2021-05-06 NBSE New 52 Week Closing Low Bearish
2021-05-06 NBSE New 52 Week Low Weakness
2021-05-06 NBSE Expansion Breakdown Bearish Swing Setup
2021-05-06 PTCT Lower Bollinger Band Walk Weakness
2021-05-06 SLDB Bollinger Band Squeeze Range Contraction
2021-05-06 SLDB Stochastic Reached Oversold Weakness
2021-05-06 SMMT Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-05-06 SMMT 50 DMA Support Bullish
2021-05-06 SRPT Pocket Pivot Bullish Swing Setup
2021-05-06 SRPT Upper Bollinger Band Walk Strength
2021-05-06 TVTX 20 DMA Resistance Bearish
2021-05-06 TVTX Doji - Bullish? Reversal
2021-05-06 TVTX Stochastic Reached Oversold Weakness
2021-05-06 TVTX Lower Bollinger Band Walk Weakness
2021-05-06 TVTX Fell Below 200 DMA Bearish
2021-05-06 WVE Lower Bollinger Band Walk Weakness

Recent News for Dystrophy Stocks

Date Stock Title
May 6 FIXX Homology Medicines (FIXX) Reports Q1 Loss, Tops Revenue Estimates
May 6 FIXX Homology Medicines EPS beats by $0.62, beats on revenue
May 6 TVTX Travere Therapeutics EPS misses by $0.25, misses on revenue
May 6 FIXX Homology Medicines Reports First Quarter 2021 Financial Results and Recent Highlights
May 6 TVTX Travere Therapeutics Reports First Quarter 2021 Financial Results
May 6 PTCT PTC Therapeutics, Inc. (PTCT) CEO Stuart Peltz on Q1 2021 Results - Earnings Call Transcript
May 6 IONS Ionis (IONS) Q1 Loss Widens Year Over Year, Sales Miss
May 6 FULC Fulcrum Therapeutics, Inc. (FULC) Reports Q1 Loss, Tops Revenue Estimates
May 6 BMY DarwinHealth Announces a Research Collaboration with Bristol Myers Squibb for a Novel Cancer Target Discovery (NCTI) Initiative
May 6 FULC Fulcrum Therapeutics has a new medical chief
May 6 DYN Dyne Therapeutics EPS beats by $0.10
May 6 LIFE aTyr Pharma to Webcast Conference Call Reporting First Quarter 2021 Financial Results
May 6 SMMT Summit Therapeutics Publishes Scientific Updates to Corporate Website
May 6 DYN Dyne Therapeutics Reports First Quarter 2021 Financial Results and Business Highlights
May 6 BMY Is BMY Stock A Sell After Panel Recommends FDA Revoke An Opdivo Approval?
May 6 FULC Fulcrum Therapeutics beats on revenue
May 6 FULC Fulcrum Therapeutics Reports Recent Business Highlights and First Quarter 2021 Financial Results
May 6 FULC Fulcrum Therapeutics Appoints Christopher Morabito, M.D. as Chief Medical Officer
May 6 TVTX Earnings Scheduled For May 6, 2021
May 6 SRPT Sarepta Therapeutics (SRPT) Q1 2021 Earnings Call Transcript

Dystrophy is the degeneration of tissue, due to disease or malnutrition, most likely due to heredity.

More about Dystrophy
Browse All Tags